Pain specialists face three different types of pain in their practice: neuropathic, nociceptive, and mixed. Neuropathic is the pain arising as a direct consequence of a lesion or disease affecting the somatosensory system 1 when nociceptive pain results from activity in neural pathways secondary to actual tissue damage or potentially tissue-damaging stimuli.2 Among the diagnostic tools that can be used to diagnose neuropathic pain is the DN4 (Douleur Neuropathique en 4 Questions), a 10-item diagnostic questionnaire that is developed by Bouhassira et al.
3We read with great interest the work of van Seventer and colleagues. 4 The authors concluded that a cutoff point of 5/10 for the Dutch Version of the DN4 resulted in a sensitivity of 75% and a specificity of 79% making thus the Dutch Version of the DN4 a diagnostic tool with a good ability to discriminate between neuropathic and nociceptive pain. We strongly believe that it is important to study the diagnostic value of DN4 in different languages as it has been shown that in different languages the cutoff points might differ slightly.3-6 Therefore, we congratulate the authors for undertaking this project.We have some concerns, however, regarding the statistical analysis. At the moment, we are analyzing data from our patients to estimate the diagnostic value of the Greek Version of DN4, and we feel that a different approach is more clinically relevant. More specifically, van Seventer and colleagues limited the analysis to patients who were diagnosed with either neuropathic or nociceptive pain by two different pain specialists. However, patients with mixed pain have not been included in the analysis, a fact that might have altered the true cutoff point of the DN4 questionnaire that would indicate a neuropathic element of pain.DN4 is a tool that can also be used by nonspecialists 3 with or even without bedside testing. 5 Moreover, Attal et al. 7 confirmed the psychometric properties of the DN4 questionnaire to assess the neuropathic component in patients with mixed pain. In addition, Raptis et al. 8 have used the DN4 questionnaire in identifying the neuropathic component of pain in patients with cancer. For these reasons, including patients with mixed pain in the analysis would be a more clinically real scenario and therefore obtaining a cutoff score after analyzing all three categories of pain would be of more clinical use even in nonspecialists who are treating patients presenting with pain.As treatment strategies vary between nociceptive and neuropathic pain, identifying the neuropathic component -even in the form of a mixed pain -is crucial in treating the pain adequately.
REPLY BY THE AUTHORSTo the Editor: Firstly, the authors would like to thank the Editor for the opportunity to respond.Secondly, we would like to express our sincere thanks to the responders on our article entitled "Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain" for their positive comments and for pointing out some concerns regarding the statistical a...